nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1B1—Mitoxantrone—lymphatic system cancer	0.24	0.343	CbGbCtD
Propofol—CYP1A2—Carmustine—lymphatic system cancer	0.0999	0.143	CbGbCtD
Propofol—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0812	0.116	CbGbCtD
Propofol—CYP2C19—Teniposide—lymphatic system cancer	0.0728	0.104	CbGbCtD
Propofol—CYP2C9—Teniposide—lymphatic system cancer	0.0605	0.0865	CbGbCtD
Propofol—CYP3A4—Cytarabine—lymphatic system cancer	0.0357	0.0511	CbGbCtD
Propofol—CYP3A4—Teniposide—lymphatic system cancer	0.0352	0.0503	CbGbCtD
Propofol—ALB—Methotrexate—lymphatic system cancer	0.0327	0.0468	CbGbCtD
Propofol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0246	0.0352	CbGbCtD
Propofol—CYP3A4—Vincristine—lymphatic system cancer	0.0169	0.0242	CbGbCtD
Propofol—Pharyngitis—Fludarabine—lymphatic system cancer	0.00124	0.0041	CcSEcCtD
Propofol—Visual impairment—Fludarabine—lymphatic system cancer	0.0012	0.00398	CcSEcCtD
Propofol—Hypoxia—Methotrexate—lymphatic system cancer	0.00116	0.00384	CcSEcCtD
Propofol—Diplopia—Carmustine—lymphatic system cancer	0.00115	0.00382	CcSEcCtD
Propofol—Agitation—Teniposide—lymphatic system cancer	0.00113	0.00376	CcSEcCtD
Propofol—Bronchospasm—Bleomycin—lymphatic system cancer	0.00112	0.00372	CcSEcCtD
Propofol—Chills—Fludarabine—lymphatic system cancer	0.00112	0.00371	CcSEcCtD
Propofol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00111	0.00369	CcSEcCtD
Propofol—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00111	0.00367	CcSEcCtD
Propofol—Pain in extremity—Vincristine—lymphatic system cancer	0.0011	0.00365	CcSEcCtD
Propofol—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.0011	0.00364	CcSEcCtD
Propofol—Hypertension—Teniposide—lymphatic system cancer	0.00106	0.00354	CcSEcCtD
Propofol—Chest pain—Teniposide—lymphatic system cancer	0.00105	0.00349	CcSEcCtD
Propofol—Urinary retention—Vincristine—lymphatic system cancer	0.00105	0.00347	CcSEcCtD
Propofol—Cardiac arrest—Vincristine—lymphatic system cancer	0.00105	0.00347	CcSEcCtD
Propofol—Dehydration—Vincristine—lymphatic system cancer	0.00102	0.0034	CcSEcCtD
Propofol—Confusional state—Teniposide—lymphatic system cancer	0.00101	0.00337	CcSEcCtD
Propofol—Oedema—Teniposide—lymphatic system cancer	0.00101	0.00334	CcSEcCtD
Propofol—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.001	0.00333	CcSEcCtD
Propofol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.001	0.00333	CcSEcCtD
Propofol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000996	0.00331	CcSEcCtD
Propofol—Agitation—Fludarabine—lymphatic system cancer	0.000996	0.00331	CcSEcCtD
Propofol—Dehydration—Mitoxantrone—lymphatic system cancer	0.000995	0.00331	CcSEcCtD
Propofol—Tachycardia—Teniposide—lymphatic system cancer	0.000982	0.00326	CcSEcCtD
Propofol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.000973	0.00323	CcSEcCtD
Propofol—Pruritus—Mechlorethamine—lymphatic system cancer	0.000965	0.00321	CcSEcCtD
Propofol—Cough—Fludarabine—lymphatic system cancer	0.000945	0.00314	CcSEcCtD
Propofol—Hypotension—Teniposide—lymphatic system cancer	0.00094	0.00312	CcSEcCtD
Propofol—Convulsion—Fludarabine—lymphatic system cancer	0.000939	0.00312	CcSEcCtD
Propofol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000934	0.0031	CcSEcCtD
Propofol—Myalgia—Fludarabine—lymphatic system cancer	0.000922	0.00306	CcSEcCtD
Propofol—Haemoglobin—Bleomycin—lymphatic system cancer	0.000917	0.00305	CcSEcCtD
Propofol—Haemorrhage—Bleomycin—lymphatic system cancer	0.000912	0.00303	CcSEcCtD
Propofol—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000901	0.00299	CcSEcCtD
Propofol—Hyperglycaemia—Carmustine—lymphatic system cancer	0.000898	0.00298	CcSEcCtD
Propofol—Dyspnoea—Teniposide—lymphatic system cancer	0.000897	0.00298	CcSEcCtD
Propofol—Confusional state—Fludarabine—lymphatic system cancer	0.000892	0.00296	CcSEcCtD
Propofol—Depression—Carmustine—lymphatic system cancer	0.000885	0.00294	CcSEcCtD
Propofol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000884	0.00294	CcSEcCtD
Propofol—Oedema—Fludarabine—lymphatic system cancer	0.000884	0.00294	CcSEcCtD
Propofol—Renal failure—Carmustine—lymphatic system cancer	0.000872	0.0029	CcSEcCtD
Propofol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00087	0.00289	CcSEcCtD
Propofol—Vomiting—Mechlorethamine—lymphatic system cancer	0.000868	0.00288	CcSEcCtD
Propofol—Apnoea—Methotrexate—lymphatic system cancer	0.000867	0.00288	CcSEcCtD
Propofol—Rash—Mechlorethamine—lymphatic system cancer	0.00086	0.00286	CcSEcCtD
Propofol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00086	0.00286	CcSEcCtD
Propofol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000855	0.00284	CcSEcCtD
Propofol—Flushing—Bleomycin—lymphatic system cancer	0.000847	0.00281	CcSEcCtD
Propofol—Depression—Vincristine—lymphatic system cancer	0.000845	0.00281	CcSEcCtD
Propofol—Extravasation—Methotrexate—lymphatic system cancer	0.000842	0.0028	CcSEcCtD
Propofol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000835	0.00277	CcSEcCtD
Propofol—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000834	0.00277	CcSEcCtD
Propofol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00083	0.00276	CcSEcCtD
Propofol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00083	0.00276	CcSEcCtD
Propofol—Feeling abnormal—Teniposide—lymphatic system cancer	0.000829	0.00275	CcSEcCtD
Propofol—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.000819	0.00272	CcSEcCtD
Propofol—Chills—Bleomycin—lymphatic system cancer	0.000819	0.00272	CcSEcCtD
Propofol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000813	0.0027	CcSEcCtD
Propofol—Renal failure—Mitoxantrone—lymphatic system cancer	0.000811	0.00269	CcSEcCtD
Propofol—Nausea—Mechlorethamine—lymphatic system cancer	0.000811	0.00269	CcSEcCtD
Propofol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000809	0.00269	CcSEcCtD
Propofol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000806	0.00268	CcSEcCtD
Propofol—Haemoglobin—Carmustine—lymphatic system cancer	0.000801	0.00266	CcSEcCtD
Propofol—Urticaria—Teniposide—lymphatic system cancer	0.000799	0.00265	CcSEcCtD
Propofol—Oliguria—Methotrexate—lymphatic system cancer	0.000797	0.00265	CcSEcCtD
Propofol—Haemorrhage—Carmustine—lymphatic system cancer	0.000796	0.00265	CcSEcCtD
Propofol—Abdominal pain—Teniposide—lymphatic system cancer	0.000795	0.00264	CcSEcCtD
Propofol—Body temperature increased—Teniposide—lymphatic system cancer	0.000795	0.00264	CcSEcCtD
Propofol—Erythema—Bleomycin—lymphatic system cancer	0.000794	0.00264	CcSEcCtD
Propofol—Paraesthesia—Fludarabine—lymphatic system cancer	0.000794	0.00264	CcSEcCtD
Propofol—Hallucination—Carmustine—lymphatic system cancer	0.000792	0.00263	CcSEcCtD
Propofol—Dyspnoea—Fludarabine—lymphatic system cancer	0.000788	0.00262	CcSEcCtD
Propofol—Visual impairment—Carmustine—lymphatic system cancer	0.000768	0.00255	CcSEcCtD
Propofol—Fatigue—Fludarabine—lymphatic system cancer	0.000762	0.00253	CcSEcCtD
Propofol—Hallucination—Vincristine—lymphatic system cancer	0.000757	0.00251	CcSEcCtD
Propofol—Pain—Fludarabine—lymphatic system cancer	0.000756	0.00251	CcSEcCtD
Propofol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000754	0.0025	CcSEcCtD
Propofol—Respiratory failure—Methotrexate—lymphatic system cancer	0.000748	0.00249	CcSEcCtD
Propofol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000744	0.00247	CcSEcCtD
Propofol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00074	0.00246	CcSEcCtD
Propofol—Flushing—Carmustine—lymphatic system cancer	0.000739	0.00246	CcSEcCtD
Propofol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000735	0.00244	CcSEcCtD
Propofol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000729	0.00242	CcSEcCtD
Propofol—Asthenia—Teniposide—lymphatic system cancer	0.000722	0.0024	CcSEcCtD
Propofol—Pruritus—Teniposide—lymphatic system cancer	0.000712	0.00236	CcSEcCtD
Propofol—Arrhythmia—Carmustine—lymphatic system cancer	0.000712	0.00236	CcSEcCtD
Propofol—Body temperature increased—Fludarabine—lymphatic system cancer	0.000699	0.00232	CcSEcCtD
Propofol—Erythema—Carmustine—lymphatic system cancer	0.000693	0.0023	CcSEcCtD
Propofol—Cough—Bleomycin—lymphatic system cancer	0.000693	0.0023	CcSEcCtD
Propofol—Diarrhoea—Teniposide—lymphatic system cancer	0.000688	0.00229	CcSEcCtD
Propofol—Chest pain—Bleomycin—lymphatic system cancer	0.000676	0.00225	CcSEcCtD
Propofol—Myalgia—Bleomycin—lymphatic system cancer	0.000676	0.00225	CcSEcCtD
Propofol—Chills—Mitoxantrone—lymphatic system cancer	0.000664	0.00221	CcSEcCtD
Propofol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000661	0.0022	CcSEcCtD
Propofol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000654	0.00217	CcSEcCtD
Propofol—Confusional state—Bleomycin—lymphatic system cancer	0.000654	0.00217	CcSEcCtD
Propofol—Tremor—Carmustine—lymphatic system cancer	0.00065	0.00216	CcSEcCtD
Propofol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000648	0.00215	CcSEcCtD
Propofol—Oedema—Bleomycin—lymphatic system cancer	0.000648	0.00215	CcSEcCtD
Propofol—Erythema—Mitoxantrone—lymphatic system cancer	0.000645	0.00214	CcSEcCtD
Propofol—Vomiting—Teniposide—lymphatic system cancer	0.00064	0.00212	CcSEcCtD
Propofol—Sepsis—Methotrexate—lymphatic system cancer	0.000638	0.00212	CcSEcCtD
Propofol—Agitation—Carmustine—lymphatic system cancer	0.000637	0.00212	CcSEcCtD
Propofol—Asthenia—Fludarabine—lymphatic system cancer	0.000634	0.00211	CcSEcCtD
Propofol—Rash—Teniposide—lymphatic system cancer	0.000634	0.00211	CcSEcCtD
Propofol—Dermatitis—Teniposide—lymphatic system cancer	0.000634	0.00211	CcSEcCtD
Propofol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000631	0.0021	CcSEcCtD
Propofol—Headache—Teniposide—lymphatic system cancer	0.00063	0.00209	CcSEcCtD
Propofol—Pruritus—Fludarabine—lymphatic system cancer	0.000626	0.00208	CcSEcCtD
Propofol—Agitation—Vincristine—lymphatic system cancer	0.000608	0.00202	CcSEcCtD
Propofol—Hypotension—Bleomycin—lymphatic system cancer	0.000606	0.00201	CcSEcCtD
Propofol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000605	0.00201	CcSEcCtD
Propofol—Convulsion—Carmustine—lymphatic system cancer	0.000601	0.002	CcSEcCtD
Propofol—Hypertension—Carmustine—lymphatic system cancer	0.000599	0.00199	CcSEcCtD
Propofol—Nausea—Teniposide—lymphatic system cancer	0.000598	0.00199	CcSEcCtD
Propofol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000591	0.00196	CcSEcCtD
Propofol—Myalgia—Carmustine—lymphatic system cancer	0.00059	0.00196	CcSEcCtD
Propofol—Chest pain—Carmustine—lymphatic system cancer	0.00059	0.00196	CcSEcCtD
Propofol—Anxiety—Carmustine—lymphatic system cancer	0.000588	0.00195	CcSEcCtD
Propofol—Paraesthesia—Bleomycin—lymphatic system cancer	0.000582	0.00193	CcSEcCtD
Propofol—Dyspnoea—Bleomycin—lymphatic system cancer	0.000578	0.00192	CcSEcCtD
Propofol—Convulsion—Vincristine—lymphatic system cancer	0.000573	0.00191	CcSEcCtD
Propofol—Hypertension—Vincristine—lymphatic system cancer	0.000571	0.0019	CcSEcCtD
Propofol—Confusional state—Carmustine—lymphatic system cancer	0.000571	0.0019	CcSEcCtD
Propofol—Oedema—Carmustine—lymphatic system cancer	0.000566	0.00188	CcSEcCtD
Propofol—Myalgia—Vincristine—lymphatic system cancer	0.000563	0.00187	CcSEcCtD
Propofol—Cough—Mitoxantrone—lymphatic system cancer	0.000562	0.00187	CcSEcCtD
Propofol—Vomiting—Fludarabine—lymphatic system cancer	0.000562	0.00187	CcSEcCtD
Propofol—Convulsion—Mitoxantrone—lymphatic system cancer	0.000558	0.00186	CcSEcCtD
Propofol—Rash—Fludarabine—lymphatic system cancer	0.000557	0.00185	CcSEcCtD
Propofol—Dermatitis—Fludarabine—lymphatic system cancer	0.000557	0.00185	CcSEcCtD
Propofol—Hypertension—Mitoxantrone—lymphatic system cancer	0.000557	0.00185	CcSEcCtD
Propofol—Pain—Bleomycin—lymphatic system cancer	0.000554	0.00184	CcSEcCtD
Propofol—Headache—Fludarabine—lymphatic system cancer	0.000554	0.00184	CcSEcCtD
Propofol—Tachycardia—Carmustine—lymphatic system cancer	0.000552	0.00183	CcSEcCtD
Propofol—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000551	0.00183	CcSEcCtD
Propofol—Chest pain—Mitoxantrone—lymphatic system cancer	0.000549	0.00182	CcSEcCtD
Propofol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000549	0.00182	CcSEcCtD
Propofol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000547	0.00182	CcSEcCtD
Propofol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00054	0.00179	CcSEcCtD
Propofol—Oedema—Vincristine—lymphatic system cancer	0.00054	0.00179	CcSEcCtD
Propofol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000534	0.00177	CcSEcCtD
Propofol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00053	0.00176	CcSEcCtD
Propofol—Hypotension—Carmustine—lymphatic system cancer	0.000529	0.00176	CcSEcCtD
Propofol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000526	0.00175	CcSEcCtD
Propofol—Oedema—Mitoxantrone—lymphatic system cancer	0.000526	0.00175	CcSEcCtD
Propofol—Nausea—Fludarabine—lymphatic system cancer	0.000525	0.00174	CcSEcCtD
Propofol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000522	0.00173	CcSEcCtD
Propofol—Shock—Mitoxantrone—lymphatic system cancer	0.000518	0.00172	CcSEcCtD
Propofol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000516	0.00171	CcSEcCtD
Propofol—Urticaria—Bleomycin—lymphatic system cancer	0.000515	0.00171	CcSEcCtD
Propofol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000513	0.00171	CcSEcCtD
Propofol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000512	0.0017	CcSEcCtD
Propofol—Insomnia—Carmustine—lymphatic system cancer	0.000512	0.0017	CcSEcCtD
Propofol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000509	0.00169	CcSEcCtD
Propofol—Paraesthesia—Carmustine—lymphatic system cancer	0.000508	0.00169	CcSEcCtD
Propofol—Mood swings—Methotrexate—lymphatic system cancer	0.000505	0.00168	CcSEcCtD
Propofol—Hypotension—Vincristine—lymphatic system cancer	0.000505	0.00168	CcSEcCtD
Propofol—Dyspnoea—Carmustine—lymphatic system cancer	0.000504	0.00168	CcSEcCtD
Propofol—Somnolence—Carmustine—lymphatic system cancer	0.000503	0.00167	CcSEcCtD
Propofol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000492	0.00163	CcSEcCtD
Propofol—Hypotension—Mitoxantrone—lymphatic system cancer	0.000492	0.00163	CcSEcCtD
Propofol—Insomnia—Vincristine—lymphatic system cancer	0.000489	0.00162	CcSEcCtD
Propofol—Paraesthesia—Vincristine—lymphatic system cancer	0.000485	0.00161	CcSEcCtD
Propofol—Pain—Carmustine—lymphatic system cancer	0.000484	0.00161	CcSEcCtD
Propofol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000479	0.00159	CcSEcCtD
Propofol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000472	0.00157	CcSEcCtD
Propofol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000469	0.00156	CcSEcCtD
Propofol—Somnolence—Mitoxantrone—lymphatic system cancer	0.000468	0.00155	CcSEcCtD
Propofol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000466	0.00155	CcSEcCtD
Propofol—Fatigue—Vincristine—lymphatic system cancer	0.000466	0.00155	CcSEcCtD
Propofol—Asthenia—Bleomycin—lymphatic system cancer	0.000465	0.00155	CcSEcCtD
Propofol—Pain—Vincristine—lymphatic system cancer	0.000462	0.00153	CcSEcCtD
Propofol—Pruritus—Bleomycin—lymphatic system cancer	0.000459	0.00152	CcSEcCtD
Propofol—Fatigue—Mitoxantrone—lymphatic system cancer	0.000454	0.00151	CcSEcCtD
Propofol—Pancreatitis—Methotrexate—lymphatic system cancer	0.000452	0.0015	CcSEcCtD
Propofol—Pain—Mitoxantrone—lymphatic system cancer	0.00045	0.00149	CcSEcCtD
Propofol—Abdominal pain—Carmustine—lymphatic system cancer	0.000447	0.00149	CcSEcCtD
Propofol—Body temperature increased—Carmustine—lymphatic system cancer	0.000447	0.00149	CcSEcCtD
Propofol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000434	0.00144	CcSEcCtD
Propofol—Body temperature increased—Vincristine—lymphatic system cancer	0.000427	0.00142	CcSEcCtD
Propofol—Abdominal pain—Vincristine—lymphatic system cancer	0.000427	0.00142	CcSEcCtD
Propofol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000418	0.00139	CcSEcCtD
Propofol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000416	0.00138	CcSEcCtD
Propofol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000416	0.00138	CcSEcCtD
Propofol—Vomiting—Bleomycin—lymphatic system cancer	0.000412	0.00137	CcSEcCtD
Propofol—Depression—Methotrexate—lymphatic system cancer	0.00041	0.00136	CcSEcCtD
Propofol—Rash—Bleomycin—lymphatic system cancer	0.000409	0.00136	CcSEcCtD
Propofol—Dermatitis—Bleomycin—lymphatic system cancer	0.000408	0.00136	CcSEcCtD
Propofol—Asthenia—Carmustine—lymphatic system cancer	0.000406	0.00135	CcSEcCtD
Propofol—Renal failure—Methotrexate—lymphatic system cancer	0.000404	0.00134	CcSEcCtD
Propofol—Asthenia—Vincristine—lymphatic system cancer	0.000388	0.00129	CcSEcCtD
Propofol—Diarrhoea—Carmustine—lymphatic system cancer	0.000387	0.00129	CcSEcCtD
Propofol—Nausea—Bleomycin—lymphatic system cancer	0.000385	0.00128	CcSEcCtD
Propofol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000377	0.00125	CcSEcCtD
Propofol—Dizziness—Carmustine—lymphatic system cancer	0.000374	0.00124	CcSEcCtD
Propofol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000371	0.00123	CcSEcCtD
Propofol—Diarrhoea—Vincristine—lymphatic system cancer	0.00037	0.00123	CcSEcCtD
Propofol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000369	0.00123	CcSEcCtD
Propofol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000366	0.00122	CcSEcCtD
Propofol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00036	0.0012	CcSEcCtD
Propofol—Vomiting—Carmustine—lymphatic system cancer	0.00036	0.0012	CcSEcCtD
Propofol—Dizziness—Vincristine—lymphatic system cancer	0.000357	0.00119	CcSEcCtD
Propofol—Rash—Carmustine—lymphatic system cancer	0.000357	0.00119	CcSEcCtD
Propofol—Dermatitis—Carmustine—lymphatic system cancer	0.000356	0.00118	CcSEcCtD
Propofol—Visual impairment—Methotrexate—lymphatic system cancer	0.000356	0.00118	CcSEcCtD
Propofol—Headache—Carmustine—lymphatic system cancer	0.000354	0.00118	CcSEcCtD
Propofol—Tinnitus—Methotrexate—lymphatic system cancer	0.000344	0.00114	CcSEcCtD
Propofol—Vomiting—Vincristine—lymphatic system cancer	0.000343	0.00114	CcSEcCtD
Propofol—Rash—Vincristine—lymphatic system cancer	0.000341	0.00113	CcSEcCtD
Propofol—Dermatitis—Vincristine—lymphatic system cancer	0.00034	0.00113	CcSEcCtD
Propofol—Headache—Vincristine—lymphatic system cancer	0.000338	0.00112	CcSEcCtD
Propofol—Nausea—Carmustine—lymphatic system cancer	0.000336	0.00112	CcSEcCtD
Propofol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000334	0.00111	CcSEcCtD
Propofol—Rash—Mitoxantrone—lymphatic system cancer	0.000332	0.0011	CcSEcCtD
Propofol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000331	0.0011	CcSEcCtD
Propofol—Chills—Methotrexate—lymphatic system cancer	0.000331	0.0011	CcSEcCtD
Propofol—Headache—Mitoxantrone—lymphatic system cancer	0.00033	0.00109	CcSEcCtD
Propofol—Erythema—Methotrexate—lymphatic system cancer	0.000321	0.00107	CcSEcCtD
Propofol—Nausea—Vincristine—lymphatic system cancer	0.000321	0.00107	CcSEcCtD
Propofol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000314	0.00104	CcSEcCtD
Propofol—Nausea—Mitoxantrone—lymphatic system cancer	0.000312	0.00104	CcSEcCtD
Propofol—Cough—Methotrexate—lymphatic system cancer	0.00028	0.000931	CcSEcCtD
Propofol—Convulsion—Methotrexate—lymphatic system cancer	0.000278	0.000924	CcSEcCtD
Propofol—Chest pain—Methotrexate—lymphatic system cancer	0.000273	0.000908	CcSEcCtD
Propofol—Myalgia—Methotrexate—lymphatic system cancer	0.000273	0.000908	CcSEcCtD
Propofol—Confusional state—Methotrexate—lymphatic system cancer	0.000264	0.000878	CcSEcCtD
Propofol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000262	0.000871	CcSEcCtD
Propofol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000253	0.000842	CcSEcCtD
Propofol—Hypotension—Methotrexate—lymphatic system cancer	0.000245	0.000814	CcSEcCtD
Propofol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000239	0.000793	CcSEcCtD
Propofol—Insomnia—Methotrexate—lymphatic system cancer	0.000237	0.000788	CcSEcCtD
Propofol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000235	0.000782	CcSEcCtD
Propofol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000234	0.000776	CcSEcCtD
Propofol—Somnolence—Methotrexate—lymphatic system cancer	0.000233	0.000774	CcSEcCtD
Propofol—Fatigue—Methotrexate—lymphatic system cancer	0.000226	0.000751	CcSEcCtD
Propofol—Pain—Methotrexate—lymphatic system cancer	0.000224	0.000745	CcSEcCtD
Propofol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000216	0.000717	CcSEcCtD
Propofol—Urticaria—Methotrexate—lymphatic system cancer	0.000208	0.000692	CcSEcCtD
Propofol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000207	0.000688	CcSEcCtD
Propofol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000207	0.000688	CcSEcCtD
Propofol—Asthenia—Methotrexate—lymphatic system cancer	0.000188	0.000625	CcSEcCtD
Propofol—Pruritus—Methotrexate—lymphatic system cancer	0.000185	0.000616	CcSEcCtD
Propofol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000179	0.000596	CcSEcCtD
Propofol—Dizziness—Methotrexate—lymphatic system cancer	0.000173	0.000576	CcSEcCtD
Propofol—Vomiting—Methotrexate—lymphatic system cancer	0.000167	0.000554	CcSEcCtD
Propofol—Rash—Methotrexate—lymphatic system cancer	0.000165	0.000549	CcSEcCtD
Propofol—Dermatitis—Methotrexate—lymphatic system cancer	0.000165	0.000548	CcSEcCtD
Propofol—Headache—Methotrexate—lymphatic system cancer	0.000164	0.000545	CcSEcCtD
Propofol—Nausea—Methotrexate—lymphatic system cancer	0.000156	0.000517	CcSEcCtD
